Learning Banner overlay

You never stop learning

Advancement options become plentiful as more practitioners embrace further learning

12 Jul 2018 by Emily McCormick

Optics is an interesting sector when it comes to education post qualification. Besides the CET requirements, there is a plethora of options available to qualified optometrists who wish to advance, upskill and simply keep on learning.

While it is the individual’s choice to take further or higher qualifications, many are embracing these opportunities to enable them to stand out from the crowd on the High Street and deliver a higher level of patient care – MECS, a professional certificate in glaucoma, medical retina or paediatrics eye care, or independent prescribing (IP) anyone? I could go on…

Independent prescribing was introduced in 2009, with a cohort of optometrists now trained to prescribe any licensed medicine for conditions affecting the eye within their expertise and competence, with this number growing.

In OT’s August Future of optics-themed edition, which will land through your letterboxes at the end of the month, we speak to IP-optometrist Gillian Bruce who, as well as being IP qualified, also has an MSc in primary care ophthalmology and has recently applied for the Professional Certificate in Paediatric Optometry. Ms Bruce shares that furthering her knowledge both challenges her and helps her keep the practice where she works ahead of the field.

The AOP’s Therapeutics conference, which is run annually in partnership with SECO International, comes to London in September with keynote speakers addressing topics ranging from neuroimaging of neuro-ophthalmic disorders and autofluorescence in retinal pathology diagnosis to getting started with gonioscopy and tissue engineering.

Offering CET that covers all of the competencies required by independent prescribers, the two-day event is also suitable for those considering the IP route.

Watch the video below from Therapeutics Manchester last month.

For more information and to book, visit the AOP website.

Image credit: Getty

Your comments

You must be logged in to join the discussion. Log in

Comments (0)